Volume 3 Issue 2 - International Pharmaceutical Industry

Current Edition

Volume 17, Issue 4

Drug Discovery, Development & Delivery v3i2

Promotion of aggregation via agitation as a Means of assessing the stability of antibody Molecules

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-9.pdf

28 April 2012 Drug Discovery, Development & Delivery v3i2 | Editorial Archive | Volume 3 Issue 2

Continue Reading →

Drug Discovery, Development & Delivery v3i2

Fighting rare Diseases

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-8.pdf

28 April 2012 Drug Discovery, Development & Delivery v3i2 | Editorial Archive | Volume 3 Issue 2

Continue Reading →

Drug Discovery, Development & Delivery v3i2

RGCC: A Leading Company in Analysis of CSCs as Progenitors of All Cancer Relapses

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-7.pdf

28 April 2012 Drug Discovery, Development & Delivery v3i2 | Editorial Archive | Volume 3 Issue 2

Continue Reading →

Drug Discovery, Development & Delivery v3i2

Improving the human relevance of Preclinical trials

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-6.pdf

28 April 2012 Drug Discovery, Development & Delivery v3i2 | Editorial Archive | Volume 3 Issue 2

Continue Reading →

Drug Discovery, Development & Delivery v3i2

A highly regulated environment for biomarker and biopharmaceutical testing

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-5.pdf

28 April 2012 Drug Discovery, Development & Delivery v3i2 | Editorial Archive | Volume 3 Issue 2

Continue Reading →

Drug Discovery, Development & Delivery v3i2

Insect Models for Drug Discovery

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-4.pdf

28 April 2012 Drug Discovery, Development & Delivery v3i2 | Editorial Archive | Volume 3 Issue 2

Continue Reading →

Editorial Archive

Recent trends in Personalised Medicine

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-3.pdf

28 April 2012 Editorial Archive | Regulatory & Marketplace v3i2 | Volume 3 Issue 2

Continue Reading →

Editorial Archive

The challenges of e-Publishing in regulatory affairs

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-2.pdf

28 April 2012 Editorial Archive | Regulatory & Marketplace v3i2 | Volume 3 Issue 2

Continue Reading →

Editorial Archive

Risk Management of Drug safety: Pre-Approval Planning and Research will Ensure Success

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2.pdf

28 April 2012 Editorial Archive | Regulatory & Marketplace v3i2 | Volume 3 Issue 2

Continue Reading →